Skip to main content
Premium Trial:

Request an Annual Quote

Matchmaking Service Needed for Tumors and Treatments

Using 454 reads, researchers at Brigham and Women's Hospital sequenced tumors from four patients with mesothelioma, reports the Wall Street Journal. The researchers found that each patient had four to six mutated genes in their tumor cells compared with their healthy cells, but the patients each had different sets of mutations -- leading to speculation about drug selection. "What we need to do is pair up the right patient with the right drug," says David Sugarbaker, the lead author of the PNAS study.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.